-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LX-9211 in Postherpetic Neuralgia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LX-9211 in Postherpetic Neuralgia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LX-9211 in Postherpetic Neuralgia Drug Details: LX-9211 (BMS-986176) is under development for...
-
Product Insights
Oropharyngeal Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Oropharyngeal Cancer - Drugs In Development, 2023’, provides an overview of the Oropharyngeal Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Oropharyngeal Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Human Papillomavirus (HPV) Associated Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Human Papillomavirus (HPV) Associated Cancer - Drugs In Development, 2023’, provides an overview of the Human Papillomavirus (HPV) Associated Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Human Papillomavirus (HPV) Associated Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FIA-586 in Non-Alcoholic Steatohepatitis (NASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FIA-586 in Non-Alcoholic Steatohepatitis (NASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.FIA-586 in Non-Alcoholic Steatohepatitis (NASH)Drug Details:FIA-586 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Hpv Cd40Hvac in Oropharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Hpv Cd40Hvac in Oropharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.HPV CD40HVac in Oropharyngeal Cancer Drug Details:Vaccine is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Hpv Cd40Hvac in Human Papillomavirus (HPV) Associated Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Hpv Cd40Hvac in Human Papillomavirus (HPV) Associated Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.HPV CD40HVac in Human Papillomavirus (HPV) Associated Cancer Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Hpv Cd40Hvac in Head And Neck Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Hpv Cd40Hvac in Head And Neck Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.HPV CD40HVac in Head And Neck Cancer Drug Details:Vaccine is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AST-001 in Hepatocellular Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AST-001 in Hepatocellular Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AST-001 in Hepatocellular Carcinoma Drug Details: AST-001 is under development for treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Motixafortide Acetate in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Motixafortide Acetate in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Motixafortide Acetate in Gastric Cancer Drug Details: Motixafortide acetate (Aphexda) is...